Le corps ambivalent dans l'exposition «En imparfaite santé : la médicalisation de l'architecture» (2011-2012)

Le progrès scientifique et technologique n'est pas sans faille – les conséquences imprévues de son application peuvent causer de nouveaux problèmes. Tel est le constat machiavélien sur lequel est fondé le projet En imparfaite santé : la médicalisation de l'architecture du Centre Canadien d'Architecture (2011-2012), présenté sous forme d'exposition et de catalogue. Ce mémoire étudie comment les deux plateformes, la première étant expérientielle et la seconde théorique, formulent une critique du processus de la médicalisation actuelle, lequel est entré dans le champ de l'architecture contemporaine. L’exposition est approchée comme discours et comme installation d’objets pour un public; une attention particulière est alors portée à la scénographie et au parcours du visiteur. D’autres réflexions ont pour objet le graphisme, un outil soutenant le leitmotiv de confrontation. Dans l’étude du catalogue, l’accent est mis sur l’essai d’introduction, qui est implicitement traversé par le concept fondamentalement ambivalent de pharmakon. Le péritexte, l’encadrement physique du contenu principal de l’ouvrage, est aussi examiné. Ensuite, l’analyse comparative propose que chaque plateforme véhicule un propos différent, une stratégie rendue possible par l’ambivalence de la notion de corps, entendue littéralement et métaphoriquement. La conclusion finale du mémoire esquisse une courte proposition de contextualisation, autant de cette dualité que de la remise en question de l’autorité du discours techno-scientifique. Bien qu’En imparfaite santé dirige sa critique envers la persistance de la vision moderniste de l'architecture, nous avançons que le projet concerne tout autant, sinon plus, l'omniprésence actuelle du numérique. Ce dernier, à l’instar de l’architecture moderne, ne modifie pas seulement la conception du corps humain et architectural, il renforce également une croyance positiviste dans la technologie qui n'est pas toujours contrebalancée par la pensée critique.Scientific and technological progress is not without fault – the unforeseen consequences of its implementation may cause new problems. This is the underlying Machiavellian observation of the project Imperfect Health: the Medicalization of Architecture by the Canadian Centre for Architecture (2011-2012), presented as an exhibition and a catalogue. This dissertation studies how both platforms, the first being experiential, and the second theoretical, put forward a critique of today's medicalization process that has entered the field of contemporary architecture. The exhibition is approached as a discourse as well as an installation of objects for the public. A special focus is directed towards the scenography and the path of the visitor through it. Another aspect considered is the role of the graphic design, which serves as an instrument supporting the leitmotif of confrontation. In the study of the catalogue, the emphasis is put on the introductory essay, in which the fundamentally ambivalent concept of the pharmakon, while never stated, continually runs through it as an implicit theme. The peritext, which designates the physical framing of the catalogue’s main content, is also examined. A comparative analysis follows and concludes that each platform communicates a different message, proposing that this strategy has been made possible by the ambivalence of the concept of the body, understood literally and metaphorically. The conclusion of the dissertation presents a brief opening towards a contextualisation of this dual interpretation and of the questioning of the authority held by technical and scientific discourse. Even if Imperfect Health directs its critique towards the modernist vision of architecture that still prevails, we infer that the project is as much, if not more, about today's omnipresence of the digital. The latter, like modern architecture, does not only impact the understanding of the human and architectural body, it also reinforces a positivist belief in technology that is not always counterbalanced by critical thought

ARSB IS REQUIRED FOR BONE REMODELING

n/

How glyphosate and its associated acidity affect early development in zebrafish (Danio rerio)

Background Glyphosate is among the most extensively used pesticides worldwide. Following the ongoing highly controversial debate on this compound, its potential impact on non-target organisms is a fundamental scientific issue. In its pure compound form, glyphosate is known for its acidic properties. Methods We exposed zebrafish (Danio rerio) embryos to concentrations between 10 μM and 10 mM glyphosate in an unbuffered aqueous medium, as well as at pH 7, for 96 hours post fertilization (hpf). Furthermore, we investigated the effects of aqueous media in the range of pH 3 to 8, in comparison with 1 mM glyphosate treatment at the respective pH levels. Additionally, we exposed zebrafish to 7-deoxy-sedoheptulose (7dSh), another substance that interferes with the shikimate pathway by a mechanism analogous to that of glyphosate, at a concentration of one mM. The observed endpoints included mortality, the hatching rate, developmental delays at 24 hpf, the heart rate at 48 hpf and the malformation rate at 96 hpf. LC10/50, EC10 and, if reasonable, EC50 values were determined for unbuffered glyphosate. Results The results revealed high mortalities in all treatments associated with low pH, including high concentrations of unbuffered glyphosate (>500 μM), low pH controls and glyphosate treatments with pH 4, no mortality occurred, neither in the control nor in glyphosate treatments. At 1 mM, 7dSh did not induce any mortality, developmental delays or malformations; only slightly accelerated hatching and a decelerated heart rate were observed. Our results demonstrate that lethal impacts in zebrafish embryos can be attributed mainly to low pH, but we could also show a pH-independent effect of glyphosate on the development of zebrafish embryos on a sublethal level

Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice

Out of the 430 known solute carriers (SLC) in humans, 30% are still orphan transporters regarding structure, distribution or function. Approximately one third of all SLCs belong to the evolutionary conserved and functionally diverse Major Facilitator Superfamily (MFS). Here, we studied the orphan proteins, MFSD4A and MFSD9, which are atypical SLCs of MFS type. Hidden Markov Models were used to identify orthologues in several vertebrates, and human MFSD4A and MFSD9 share high sequence identity with their identified orthologues. MFSD4A and MFSD9 also shared more than 20% sequence identity with other phylogenetically related SLC and MFSD proteins, allowing new family clustering. Homology models displayed 12 transmembrane segments for both proteins, which were predicted to fold into a transporter-shaped structure. Furthermore, we analysed the location of MFSD4A and MFSD9 in adult mouse brain using immunohistochemistry, showing abundant neuronal protein staining. As MFSD4A and MFSD9 are plausible transporters expressed in food regulatory brain areas, we monitored transcriptional changes in several mouse brain areas after 24 hours food-deprivation and eight weeks of high-fat diet, showing that both genes were affected by altered food intake in vivo. In conclusion, we propose MFSD4A and MFSD9 to be novel transporters, belonging to disparate SLC families. Both proteins were located to neurons in mouse brain, and their mRNA expression levels were affected by the diet

Correction: Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice.

[This corrects the article DOI: 10.1371/journal.pone.0186325.]

Data from: Environmental selection is a main driver of divergence in house sparrows (Passer domesticus) in Romania and Bulgaria

Both neutral and adaptive evolutionary processes can cause population divergence, but their relative contributions remain unclear. We investigated the roles of these processes in population divergence in house sparrows (Passer domesticus) from Romania and Bulgaria, regions characterized by high landscape heterogeneity compared to Western Europe. We asked whether morphological divergence, complemented with genetic data in this human commensal species, was best explained by environmental variation, geographic distance, or landscape resistance—the effort it takes for an individual to disperse from one location to the other—caused by either natural or anthropogenic barriers. Using generalized dissimilarity modeling, a matrix regression technique that fits biotic beta diversity to both environmental predictors and geographic distance, we found that a small set of climate and vegetation variables explained up to ~30% of the observed divergence, whereas geographic and resistance distances played much lesser roles. Our results are consistent with signals of selection on morphological traits and of isolation by adaptation in genetic markers, suggesting that selection by natural environmental conditions shapes population divergence in house sparrows. Our study thus contributes to a growing body of evidence that adaptive evolution may be a major driver of diversification